Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: A. Richey Sharrett Clear advanced filters
  • A cohort study of over 15,000 US adults found that the lifetime risk of developing dementia from ages 55 to 95 is 42%, with the highest risk in APOE ε4 carriers, women and Black adults, and projected that approximately 1 million US adults will develop dementia annually by 2060.

    • Michael Fang
    • Jiaqi Hu
    • Josef Coresh
    Research
    Nature Medicine
    Volume: 31, P: 772-776
  • The effects of statin treatment on the development of cognitive impairment, dementia and Alzheimer disease are unclear. In this Review, the authors systematically evaluate the findings from randomized controlled trials and observational studies that have investigated the association of statin use with cognition—including consideration of probable sources of bias—so as to summarize the current evidence and make recommendations for future work.

    • Melinda C. Power
    • Jennifer Weuve
    • Rebecca F. Gottesman
    Reviews
    Nature Reviews Neurology
    Volume: 11, P: 220-229